GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Frontage Holdings Corp (HKSE:01521) » Definitions » Momentum Rank

Frontage Holdings (HKSE:01521) Momentum Rank : 5 (As of Jun. 02, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Frontage Holdings Momentum Rank?

Frontage Holdings has the Momentum Rank of 5.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Competitive Comparison of Frontage Holdings's Momentum Rank

For the Biotechnology subindustry, Frontage Holdings's Momentum Rank, along with its competitors' market caps and Momentum Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Frontage Holdings's Momentum Rank Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Frontage Holdings's Momentum Rank distribution charts can be found below:

* The bar in red indicates where Frontage Holdings's Momentum Rank falls into.



Frontage Holdings Momentum Rank Related Terms

Thank you for viewing the detailed overview of Frontage Holdings's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Frontage Holdings (HKSE:01521) Business Description

Traded in Other Exchanges
Address
700 Pennsylvania Drive, Exton, PA, USA, 19341
Frontage Holdings Corp is a contract research organization providing integrated, scientifically driven research, analytical and development services. Geographically the group operates in both PRC and North America. The services provided in the North American segment, include Bioanalytical, CMC, DMPK and Safety and Toxicology services in the USA and Canada. The service offered in PRC includes Bioanalytical, Bioequivalence and CMC services in the PRC. Further, it also provides bioanalytical services, which are offered throughout the drug discovery and development process both in the United States and China.
Executives
Hang Zhou Tai Ge Yi Yao Ke Ji Gu Fen You Xian Gong Si 2101 Beneficial owner
Li Song 2101 Beneficial owner
Kabouter Management Llc 2102 Investment manager
Hangzhou Tigermed Consulting Co., Ltd.
Hongkong Tigermed Co., Limited

Frontage Holdings (HKSE:01521) Headlines

No Headlines